Russia has tested a nasal spray form of its COVID-19 vaccine that is suitable for children aged 8-12, and plans to launch the new product in September, the scientist who led the development of the Sputnik V vaccine said on Saturday.
Alexander Gintsburg, who heads the Gamaleya Institute that developed Sputnik V, said the spray for children used the same vaccine “only instead of a needle, a nozzle is put on,” the TASS news agency reported.
Read the latest updates in our dedicated coronavirus section.
The children’s shot is expected to be ready for distribution by Sept. 15, Gintsburg was quoted as saying during a meeting with President Vladimir Putin.
The research group tested the vaccine on children aged between eight and 12 and found no side effects among the test group, including no increase in body temperature, Gintsburg said in comments reported by the TASS news agency.
For the latest headlines, follow our Google News channel online or via the app.
“We are inoculating our little (patients) nasally, we are just administering the same vaccine as a nasal spray,” Gintsburg said, without giving further details about the study such as how many children were involved.
Read more:
Moscow mayor imposes ‘non-working’ week amid COVID-19 surge
Israel, New Zealand OK sale of nasal spray that could prevent COVID-19 transmission
UK scientists working on developing COVID-19 vaccine nasal spray: Report
-
Israel, New Zealand OK sale of nasal spray that could prevent COVID-19 transmission
Israel and New Zealand have given interim approval for the sale of biotech firm SaNOtize Research and Development’s Nitric Oxide Nasal Spray (NONS) ... Coronavirus -
Saudi Arabia confirms 1,077 new COVID-19 cases, 16 deaths
Saudi Arabia confirms 1,077 new COVID-19 cases over the past 24 hours, raising the total number to 464,780, the health ministry announces.Read the ... Coronavirus -
Bahrain, Russia ink deal to produce Sputnik V COVID-19 vaccine for MENA region
The sovereign funds of Russia and Bahrain signed a preliminary agreement on Thursday to manufacture and distribute the Russian Sputnik V COVID-19 ... Coronavirus -
Russia’s CoviVac more than 80 percent effective against COVID-19
Russia’s third vaccine against COVID-19, CoviVac, is more than 80 percent effective according to preliminary data, the Interfax news agency cited the ... Coronavirus